CA2712443C — 6- and 7-amino isoquinoline compounds and methods for making and using the same
Assigned to Aerie Pharmaceuticals Inc · Expires 2016-05-03 · 10y expired
What this patent protects
6- and 7-amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Phar-maceutical compositions including therapeutically effective amounts of the 6- and 7-aminoisoquinoline compounds and pharma-ceutically acceptable carriers are also pro…
USPTO Abstract
6- and 7-amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Phar-maceutical compositions including therapeutically effective amounts of the 6- and 7-aminoisoquinoline compounds and pharma-ceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.